IFITM3 regulates virus-induced inflammatory cytokine production by titrating Nogo-B orchestration of TLR responses
Author:
Clement M.ORCID, Forbester J.L., Marsden M., Sabberwal P., Wellington D., Dimonte S., Clare S., Harcourt K., Yin Z., Nobre L., Antrobus R, Jin B., Chen M., Makvandi-Nejad S., Lindborg J.A, Strittmatter S.M.ORCID, Weekes M.P.ORCID, Stanton R.J., Dong T., Humphreys I.R.
Abstract
SummaryInterferon induced transmembrane protein 3 (IFITM3) is an important viral restriction factor in viral pathogenesis that also exhibits poorly understood immune regulatory functions. Here, using human and mouse models, we demonstrate that IFITM3 regulates MyD88-dependent TLR-mediated cytokine production following dendritic cell exposure to cytomegalovirus (CMV), and this process limits viral pathogenesis in vivo. IFITM3 also restricted pro-inflammatory (IL-6) cytokine production in response to influenza. IFITM3 bound to and promoted ubiquitination and proteasomal degradation of the reticulon 4 isoform Nogo-B. We reveal that Nogo-B mediates TLR-dependent pro-inflammatory cytokine production and promotes viral pathogenesis in vivo, and this process involved alteration of TLR dynamics. The anti-inflammatory function of IFITM3 was intrinsically linked to its ability to regulate Nogo-B. Thus, we uncover Nogo-B as an unappreciated driver of viral pathogenesis and highlight a novel immune regulatory pathway where IFITM3 fine-tunes TLR responsiveness of myeloid cells to viral stimulation.
Publisher
Cold Spring Harbor Laboratory
Reference78 articles.
1. Abani, O. , Abbas, A. , Abbas, F. , Abbas, M. , Abbasi, S. , Abbass, H. , Abbott, A. , Abdallah, N. , Abdelaziz, A. , Abdelfattah, M. , et al. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2. A new role for Nogo as a regulator of vascular remodeling 3. Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response;Cell Cycle,2015 4. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans 5. The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|